Clinical trials
Other Cancer clinical trials
Below are recruiting other cancer clinical trials, each written for real people, not researchers. We’re tracking 12,892 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07472478RecruitingPhase 2
Combination drug treatment before surgery for early-stage lung cancer with KRAS G12C mutation
This study tests a new combination of drugs before surgery for people with a certain type of lung cancer (KRAS G12C). The goal is to see if these drugs can shrink the tumor and improve chances of successful surgery.
Guangzhou, Guangdong,ChinaAges 18–80 - NCT07659782RecruitingPhase 2
Study of VS-7375 for KRAS G12D lung cancer
This trial tests a new drug, VS-7375, for people with advanced non-small cell lung cancer that has a specific genetic change called KRAS G12D. It's for those who have already tried chemo and immunotherapy, and whose cancer has continued to grow.
Scottsdale, ArizonaAges 18 years+ - NCT06904066RecruitingPhase 1
Personalized T cell therapy for blood cancers
This trial tests a treatment that takes your own immune cells, modifies them to attack cancer cells, and gives them back to you. It is for people with certain blood cancers who have specific gene changes.
Bethesda, MarylandAges 18–120 - NCT07570979RecruitingPhase 1
Testing INR731 for Metastatic Prostate Cancer
This trial tests a new drug called INR731, given by mouth, for men with prostate cancer that has spread to other parts of the body. The study will check if the drug is safe and how well it works, either alone or combined with other prostate cancer medicines.
Boston, MassachusettsAges 18 years+ - NCT06561386RecruitingPhase 3
Testing a new drug combo for advanced lung cancer
This trial is comparing a new combination of two immunotherapy drugs (nivolumab and relatlimab) plus chemotherapy against the standard immunotherapy (pembrolizumab) plus chemotherapy for people with advanced non-squamous non-small cell lung cancer that has a certain protein (PD-L1) on at least 1% of its cells. The goal is to see if the new combination works better.
Mobile, AlabamaAges 18 years+ - NCT06634875RecruitingPhase 2
Test of isunakinra alone or with pembrolizumab for colorectal cancer
This trial tests a new drug combination (isunakinra plus pembrolizumab) for people with a specific type of colorectal cancer (MSS, RAS-mutated) that has a high tumor mutational burden. It may help if other treatments have stopped working.
Los Angeles, CaliforniaAges 18 years+ - NCT07888309RecruitingPhase 2
Treatment before surgery for advanced low rectal cancer
This trial tests whether adding a targeted therapy to standard chemotherapy and immunotherapy before surgery helps shrink advanced low rectal tumors more effectively. It aims to improve surgical outcomes and reduce the chance of cancer returning.
Shanghai, Shanghai MunicipalityAges 18–75 - NCT07888374Recruiting
Urine test for detecting bladder, kidney, or ureter cancer
This study tests a urine sample to see if it can find bladder, kidney, or ureter cancer and tell where it started. It may help diagnose cancer earlier without invasive procedures.
ShanghaiAges 18 years+ - NCT07889843Recruiting
Folate receptor test for high-grade ovarian cancer
This study looks at a protein called folate receptor alpha on ovarian cancer cells. It aims to understand how common this protein is, which could help guide future treatments.
AthensAges 18 years+ - NCT07725523RecruitingPhase 2/Phase 3
New imaging agent to guide prostate cancer surgery
This trial tests a new imaging agent (OTL78) that helps surgeons see prostate cancer cells during prostate removal surgery. It aims to improve the precision of the surgery and potentially reduce the chance of leaving cancer behind.
Carmel, IndianaAges 18 years+ - NCT07888140RecruitingPhase 3
Robotic versus conventional minimally invasive surgery for esophageal cancer
This trial compares two types of minimally invasive surgery for esophageal cancer: one using a robotic system and one using conventional techniques. The goal is to see if robotic surgery offers better outcomes, such as fewer complications or faster recovery.
ShanghaiAges 18 years+ - NCT07052578Recruiting
Study of Genetic Markers in High-Risk Metastatic Prostate Cancer
This study looks at men with advanced prostate cancer that has spread and is still responding to hormone therapy. It collects blood samples to check for genetic changes that might influence treatment, aiming to improve understanding of aggressive disease.
ArkhangelskAges 18 years+ - NCT07890714RecruitingPhase 1/Phase 2
A new treatment for solid tumors that have spread
This study tests a new drug called Dato-DXd in people with various solid tumors. It may help shrink tumors or slow their growth.
TaichungAges 18 years+ - NCT07563738RecruitingPhase 1/Phase 2
ODM-212 with cancer immunotherapy for advanced solid tumors
This trial tests a new drug called ODM-212 combined with existing cancer treatments for mesothelioma, pancreatic cancer, or lung cancer with a specific genetic mutation. The study aims to find the right dose and see if adding ODM-212 helps these treatments work better.
Los Angeles, CaliforniaAges 18 years+ - NCT03340506RecruitingPhase 4
Follow-on treatment study for dabrafenib and trametinib
This study lets people who finished a prior dabrafenib/trametinib trial (sponsored by Novartis or former GSK) continue those medicines if the study doctor thinks it will help. It mainly focuses on ongoing treatment benefit rather than testing a new drug.
Scottsdale, ArizonaAges 18–100 - NCT07160751Recruiting
Study of thinking and memory in people with lung cancer
This study looks at how lung cancer and its treatment might affect thinking and memory. If you are having surgery for early-stage lung cancer, you may be asked to complete online questionnaires to help researchers track these changes over time.
Paris, Île-de-France RegionAges 18–74 - NCT07222488RecruitingPhase 1/Phase 2
Study of MK-3120 for bladder cancer
This trial tests a new drug, MK-3120, for people with a specific type of bladder cancer that hasn't spread into the muscle. It is for patients who either haven't had BCG treatment before or have had BCG treatment and their cancer came back more than 12 months but within 2 years after the last dose.
Bakersfield, CaliforniaAges 18 years+ - NCT07535905RecruitingPhase 2
Tamoxifen to help testosterone return after hormone therapy
This study tests whether tamoxifen, a pill that blocks estrogen, can help your testosterone levels recover faster after you finish hormone therapy for prostate cancer. It may reduce side effects like fatigue and low sex drive.
Toronto, OntarioAges 18 years+ - NCT07621484RecruitingPhase 2
Heated chemotherapy plus immunotherapy and standard chemo for stomach cancer
This trial tests a new approach for locally advanced stomach cancer. It uses a heated chemotherapy bath (HIPEC) before giving a combination of two chemotherapy drugs (SOX or XELOX) plus an immunotherapy drug called serplulimab. This aims to shrink the tumor and improve the chances of successful surgery and long-term control.
ShanghaiAges 18–75 - NCT07787156Recruiting
Genetic testing for pancreatic cancer risk
This study offers genetic testing to people at higher risk for pancreatic cancer, especially those with a family history or certain genetic changes. It aims to help you understand your risk and possibly catch cancer early.
Boston, MassachusettsAges 18 years+ - NCT06278558Recruiting
How mindset affects growth after cancer diagnosis
This study looks at how your thoughts and feelings during early cancer treatment may lead to personal growth. It involves filling out questionnaires about your experience.
ValenciennesAges 18 years+ - NCT04235764Recruiting
Testing a new bladder-tumor surgery tool for removed tissue
This trial studies a redesigned surgical instrument used during bladder tumor removal, to see if it can improve how the removed tissue samples are collected. It may help future patients by supporting better study of bladder tissue during cancer care.
Bethesda, MarylandAges 18–120 - NCT07557342Recruiting
Sexual Health Study for Women With Gynecologic Cancer
This study looks at how gynecologic cancer (cancers of the ovaries, cervix, uterus, vulva, or vagina) affects sexual health and relationships. Researchers will talk with you and your partner about your experiences to better understand how to support sexual well-being during and after cancer treatment.
Bologna, BolognaAges 18–75 - NCT06555068RecruitingPhase 1/Phase 2
Study of HRS-6209 combinations for advanced breast cancer
This trial tests a new drug, HRS-6209, combined with different hormone treatments (fulvestrant, letrozole, HRS-8080, or HRS-1358) for people with advanced breast cancer that has spread or cannot be surgically removed and has worsened after previous treatments.
Shanghai, Shanghai MunicipalityAges 18–75
Hear when a new Other Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for other cancer?
- Yes. Clin2 currently lists 12,892 recruiting other cancer studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a other cancer trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a other cancer trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.